The Latest Breaking News from Eli Lilly

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Dow Jones pushed higher, but the Nasdaq slipped despite strong software earnings and a Fed shift toward rate cuts. Tesla Cybertruck deliveries began.

Investors can only hope stocks do as well in December as they did in November. There are definitely some S&P 500 stocks that glisten.

Zepbound is expected to be available in the U.S. by the end of the year.

Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study.

Google leads this watchlist of five S&P 500 stocks near buy points as the market rally has investors seeing green.

Eli Lilly stock is Monday's IBD Stock Of The Day. Shares are forming a new flat base after the FDA approved Lilly's new weight-loss drug.

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Biogen and Eisai scored key victories in the quest for an Alzheimer's cure. But the race is just getting started.

This iron condor trade on Eli Lilly stock has the potential to return 27% if the stock price stays between about 510 and 680.

Novo Nordisk stock slumped Monday despite unveiling promising test results for weight-loss drugs and diabetes development.